Interestingly, SLE is associated with a reduced IgG galactosylation and mechanistically, this could prevent the binding of this molecule to BDCA-2 on pDCs potentially relieving the inhibitory signaling in these cells (Kim et al, 2018). The gene discussed is CLEC4C; the disease is systemic lupus erythematosus.